Northwestern Mutual Wealth Management
ANIK icon

Northwestern Mutual Wealth Management’s Anika Therapeutics ANIK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-132
Closed -$6K – 2754
2020
Q4 		$6K Hold
132
– – ﹤0.01% 2321
2020
Q3 		$5K Buy
+132
New +$4.77K ﹤0.01% 2160
2018
Q4 		– Sell
-278
Closed -$12K – 2375
2018
Q3 		$12K Buy
+278
New +$11K ﹤0.01% 1859

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Northwestern Mutual Wealth Management's ANIK Position: Q1 2021 in Review

Northwestern Mutual Wealth Management sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 132 shares — an estimated $6K sold.

Northwestern Mutual Wealth Management first reported a position in ANIK in Q3 2018 and held it in 3 quarters. The position peaked at $12K in Q3 2018. 145 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • Northwestern Mutual Wealth Management reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 132 Anika Therapeutics shares in Q1 2021, an estimated $6K.
  • Northwestern Mutual Wealth Management first reported a position in Anika Therapeutics in Q3 2018 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Anika Therapeutics position peaked at $12K in Q3 2018.
  • 145 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2021, filed 14 May 2021.